Efficacy of radiotherapy for PV and IVC tumor thrombosis in unresectable HCC

Hepato-Gastroenterology

Volumn 54, Issue 78, 2007, Pages 1779-1782

  Sugiyama, Shinichi ^a,b   Beppu, Toru ^a   Ishiko, Takatoshi ^a   Takahashi, Masashi ^a   Masuda, Toshiro ^a   Hirata, Takahumi ^a   Imai, Katsunori ^a   Hayashi, Hiromitsu ^a   Takamori, Hiroshi ^a   Kanemitsu, Keiichiro ^a   Hirota, Masahiko ^a   Murakami, Ryuji ^a   Baba, Yuji ^a   Oya, Natsuo ^a   Yamashita, Yasuyuki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Three dimensional conformal radio therapy; Tumor thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; INFERIOR CAVA VEIN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOFREQUENCY ABLATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR THROMBUS; ULTRASOUND; UNIVARIATE ANALYSIS; VOMITING;

AGED; CARCINOMA, HEPATOCELLULAR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PORTAL VEIN; RADIOTHERAPY; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 35948987215     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cancer Therapy Evaluation Program: Common terminology criteria for adverse events, version 3.0. Int J clin Oncol 2004; 9(Suppl 3):1-64.
2. The Cancer of the Liver Italian Program Investigators: A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28:751-755.
3. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg 1990; 211:277-287.
4. Llovet JM, Bustamante J, Castells A: Natural history of nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29:62-67.
5. Fujii T, Takayasu K, Muramatsu Y: Hepatocellular carcinoma with portal thombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993; 23:105-109.
6. Minagawa M, Makuuchi M, Takayama T: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233:379-384.
7. Yamashita Y, Takahashi M, Koga Y: Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991; 67:385-391.
8. Bismuth H, Morino M, Sherlock D: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163:387-394.
9. Lee HS, Kim JS, Choi IJ: The safety and Efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Cancer 1997; 79:2087-2094.
10. Chung JW, Park JH, Han JK: Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Am J Roentgenol 1995; 165:315-321.
11. Ando E, Tanaka M, Yamashita F: Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002; 95:588-595.
12. Itamoto T, Nakahara H, Tashiro H: Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol 2002; 80:143-148.
13. Matsuzaki Y, Osuga T, Saito Y: A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 1994; 106:1032-1041.
14. Cheng SH, Lin YM, Chuang VP: A pilot study of three-dimmensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14:1025-1033.
15. Zeng ZC, Fan J, Tang ZY: A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phy 2005; 61:432-443.
16. Yamada K, Soejima T, Sugimoto K: Pilot study of local radiotherapy for portal vein thrombus in patients with unresectable hepatocellular carcinoma. Jpn J Clin Oncol 2001; 31:147-152.
17. Kaneko S, Urabe T, Kobayashi K: Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology 2002; 62(Suppl 1):69-73.
18. Sakon M, Nagano H, Dono K: Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94:435-442.